 4. Medications for treatment of heart failure such as ACE inhibitors, angiotensin receptor blockers ARBs, beta-blockers or aldosterone antagonists. Use of such medications for approved indications such as hypertension, post-MI management without known LV dysfunction or for diabetic nephropathy is permitted. protocol amended to remove this criteria 